Roche signs Dx development deal with Pacific Biosciences

09/26/2013 | American City Business Journals

Pacific Biosciences of California has struck a deal to develop and sell sequencing tools and consumables exclusively to Roche Diagnostics. Pacific Biosciences will receive $35 million in cash and potentially $40 million more from the deal, which also gives Roche exclusive rights to use the technologies for nucleic acid sequencing for in vitro diagnostics for humans.

View Full Article in:

American City Business Journals

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA